NA
Device Neuro
PDI 07613327129243
General payments
$1,215,217
Research payments
$31,810
Through program year 2025, $1,215,217 in general payments and $31,810 in research payments were reported against NA (Neuro).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $153,836 | 1,259 |
| 2024 | General | $395,165 | 1,122 |
| 2024 | Research | $7,524 | 1 |
| 2023 | General | $278,682 | 852 |
| 2023 | Research | $23,436 | 2 |
| 2022 | General | $254,829 | 536 |
| 2021 | General | $132,706 | 447 |
| 2021 | Research | $850 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 53 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,216 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.